J. Barnes

Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 4. 3-[2-(Benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2(1H)-one and analogues.

Christopher M Thomas, J. Hoffman, J. Wai, 1993, Journal of medicinal chemistry.

Inhibitors of NQO1: identification of compounds more potent than dicoumarol without associated off-target effects.

I. Stratford, K. Nolan, K. Scott, 2011, Biochemical pharmacology.

Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1).

M. Dunstan, I. Stratford, D. Ross, 2009, Journal of medicinal chemistry.

Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2.

I. Stratford, K. Nolan, R. Bryce, 2010, Bioorganic & medicinal chemistry.

Novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2): crystal structures, biochemical activity, and intracellular effects of imidazoacridin-6-ones.

M. Dunstan, I. Stratford, K. Nolan, 2011, Journal of medicinal chemistry.

Pharmacological inhibitors of NAD(P)H quinone oxidoreductase, NQO1: structure/activity relationships and functional activity in tumour cells.

I. Stratford, K. Nolan, K. Scott, 2010, Biochemical pharmacology.